Thiamphenicol

CAS No. 15318-45-3

Thiamphenicol ( NSC 522822; (+)-Thiamphenicol; Thiophenicol; WIN 5,603-2 )

Catalog No. M12153 CAS No. 15318-45-3

Thiamphenicol is an antimicrobial antibiotic and a methyl-sulfonyl analogue of chloramphenicol.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 35 In Stock
100MG 48 In Stock
200MG 60 In Stock
500MG 69 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Thiamphenicol
  • Note
    Research use only, not for human use.
  • Brief Description
    Thiamphenicol is an antimicrobial antibiotic and a methyl-sulfonyl analogue of chloramphenicol.
  • Description
    Thiamphenicol is an antimicrobial antibiotic and a methyl-sulfonyl analogue of chloramphenicol.
  • Synonyms
    NSC 522822; (+)-Thiamphenicol; Thiophenicol; WIN 5,603-2
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    15318-45-3
  • Formula Weight
    356.22
  • Molecular Formula
    C12H15Cl2NO5S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 71 mg/mL (199.31 mM)
  • SMILES
    O=C(N[C@H](CO)[C@H](O)C1=CC=C(S(=O)(C)=O)C=C1)C(Cl)Cl
  • Chemical Name
    2,2-dichloro-N-((1R,2R)-1,3-dihydroxy-1-(4-(methylsulfonyl)phenyl)propan-2-yl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Berman HM, et al. Nucleic Acids Res. 2000 Jan 1; 28(1): 235-42.
molnova catalog
related products
  • N-Benzylpalmitamide

    N-benzylpalmitamide inhibits fatty acid amide hydrolase (FAAH) in a time-dependent manner and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders.

  • Silibinin

    Silibinin, the main flavonoid extracted from the milk thistle Silybum marianum, displays hepatoprotective properties in acute and chronic liver injury.

  • Corynoxeine

    Corynoxeine is a potent ERK1/2 inhibitor of key PDGF-BB-induced VSMC proliferation and may be useful in the prevention and treatment of vascular diseases and restenosis after angioplasty.